Avid Bioservices Inc (CDMO)

[cjgaddy]

Was waiting on the next PPHM/Ronin/Shareholders to update, but I think it's time to add SITC'17 regardless...
See:
Nov8-12 2017: “(SITC) Society for Immunotherapy of Cancer 32nd Annual Meeting”, Natl-Harbor MD
http://investorshub.advfn.com/boards/manage_msg.asp?message_id=134756056

KNOWN UPCOMING:
Sep25-28/Avid(booth #918): Informa’s BPI’17: BioProcess Intl. Conf. & Exhibition, Boston https://lifesciences.knect365.com/bioprocessinternational
Oct2/NCI Scientist Gregoire Altan-Bonnet(MSKCC ties), AACR’s Tumor Immunotherapy Conf., Boston http://tinyurl.com/y74v76go
...“Long-Lived Disruption of Inflammation Stems from the Catch-and-Release of Cytokines Mediated by Surface Phosphatidylserine in Tumors”
Oct6/Avid(booth): LakePharma Protein Eng. Symposium, So.SanFran http://tinyurl.com/ya6yvetk
~Oct12(??based on 2016): Peregrine's Annual Shareholder’s Meeting (2016 attendee reports: http://tinyurl.com/jx7ouay )
Nov8-12: 32th Annual SITC’17, Natl-Harbor MD http://tinyurl.com/ybfm75wj
...1. PPHM-PrecisionMed: “Results of Epigenetic-Based Quantitative PCR Assisted Immune Cell Counting Analysis in Bavi SUNRISE Trial Subgroup”
...2. MSKCC-PPHM: “PS-Targeting In Combo w/Rad+Immune Checkpoint Blockade Promotes Anti-Tumor Activity in Mouse B16 Melanoma”
Dec11-15/Avid Booth #311: KNect365’s Antibody Eng. & Therapeutics Conf., SanDiego https://lifesciences.knect365.com/antibody-engineering-therapeutics
~Dec11: FY'18Q2 (qe 10-31-17) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm
Jan18-22 2018: Phacilitate’s Immunotherapy World Forum, Miami http://www.immunotherapyforum.com
...Jan18 12:30-12:45, Joe Shan(VP/Reg+Clin): “Turning up the Heat: PS-Targeting Antibodies Modulate the Tumor Microenvironment & Enhance Checkpoint Blockade”